Cite
MLA Citation
Maxime Ronot et al.. “Alternative Response Criteria (Choi, European Association for the Study of the Liver, and Modified Response Evaluation Criteria in Solid Tumors [RECIST]) Versus RECIST 1.1 in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib.” Oncologist, vol. 19, 2014, pp. 394–402. http://access.bl.uk/ark:/81055/vdc_100054356968.0x000024